Krystal Biotech Current Assets

Krystal Biotech (KRYS) currently reports a current assets of $1B as of March 2026. That compares with $770M in the prior-year period — up 33.0% year over year. Use the charts on this page to explore Krystal Biotech's current assets history and peer comparisons.

Krystal Biotech's current assets increased from $770M to $1B — a 33.0% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Krystal Biotech reported $1B in current assets as of March 2026. That compares with $770M in the prior-year period — up 33.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $1B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Krystal Biotech, and consider following KRYS for alerts when major investors trade the stock.

Krystal Biotech is classified in the Healthcare sector. On current assets, it currently shows $1B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing KRYS with unrelated industries.